99 related articles for article (PubMed ID: 2242010)
1. Hepatic subcellular localization of cresylbenzodioxaphosphorin oxide (CBDP)-sensitive soman binding sites.
Little JS; Maxwell DM; Fox-Talbot MK; Brecht K; Lenz DE
Biochem Pharmacol; 1990 Oct; 40(8):1733-7. PubMed ID: 2242010
[TBL] [Abstract][Full Text] [Related]
2. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
Maxwell DM; Brecht KM; O'Neill BL
Toxicol Lett; 1987 Nov; 39(1):35-42. PubMed ID: 3672554
[TBL] [Abstract][Full Text] [Related]
3. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
Jimmerson VR; Shih TM; Maxwell DM; Mailman RB
Toxicol Lett; 1989 Jul; 48(1):93-103. PubMed ID: 2749782
[TBL] [Abstract][Full Text] [Related]
4. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice.
Clement JG
Biochem Pharmacol; 1984 Dec; 33(23):3807-11. PubMed ID: 6508835
[TBL] [Abstract][Full Text] [Related]
5. Role of aliesterase in organophosphate poisoning.
Clement JG
Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S96-105. PubMed ID: 6724216
[TBL] [Abstract][Full Text] [Related]
6. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
[TBL] [Abstract][Full Text] [Related]
7. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2-benzodioxaphosphorin-2-oxide).
Clement JG; Erhardt N
Arch Toxicol; 1990; 64(5):414-6. PubMed ID: 2403290
[TBL] [Abstract][Full Text] [Related]
8. Effect of pretreatment with CBDP on the toxicokinetics of soman stereoisomers in rats and guinea pigs.
Due AH; Trap HC; Van Der Wiel HJ; Benschop HP
Arch Toxicol; 1993; 67(10):706-11. PubMed ID: 8135661
[TBL] [Abstract][Full Text] [Related]
9. Role of carboxylesterase in protection against soman toxicity.
Purshottam T; Srivastava R
Pharmacology; 1989; 38(5):319-26. PubMed ID: 2762374
[TBL] [Abstract][Full Text] [Related]
10. Subcellular localization of non-specific carboxylesterases, acylcarnitine hydrolase, monoacylglycerol lipase and palmitoyl-CoA hydrolase in rat liver.
Mentlein R; Rix-Matzen H; Heymann E
Biochim Biophys Acta; 1988 Mar; 964(3):319-28. PubMed ID: 2894861
[TBL] [Abstract][Full Text] [Related]
11. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice.
Clement JG; Benschop HP; DeJong LP; Wolthuis OL
Toxicol Appl Pharmacol; 1987 Jun; 89(1):141-3. PubMed ID: 3590185
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of hepatic microsomal esterase activity following soman pretreatment in guinea pigs.
Luttrell WE; Castle MC
Biochem Pharmacol; 1993 Dec; 46(11):2083-92. PubMed ID: 8267657
[TBL] [Abstract][Full Text] [Related]
13. The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy.
Bosković B
Arch Toxicol; 1979 Jul; 42(3):207-16. PubMed ID: 475595
[TBL] [Abstract][Full Text] [Related]
14. A purified recombinant organophosphorus acid anhydrase protects mice against soman.
Broomfield CA
Pharmacol Toxicol; 1992 Jan; 70(1):65-6. PubMed ID: 1317565
[TBL] [Abstract][Full Text] [Related]
15. Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice.
Shapira S; Kadar T; Cohen G; Chapman S; Raveh L
Arch Toxicol; 1990; 64(8):663-8. PubMed ID: 2090035
[TBL] [Abstract][Full Text] [Related]
16. Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors.
Yang ZP; Dettbarn WD
Biochem Pharmacol; 1998 May; 55(9):1419-26. PubMed ID: 10076534
[TBL] [Abstract][Full Text] [Related]
17. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
Maxwell DM; Koplovitz I
J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
[TBL] [Abstract][Full Text] [Related]
18. Alteration of hepatic carboxylesterase activity by soman: inhibition in vitro and enhancement in vivo.
Castle MC
Xenobiotica; 1989 Jan; 19(1):115-21. PubMed ID: 2756715
[TBL] [Abstract][Full Text] [Related]
19. Stereoselectivity of enzymes involved in toxicity and detoxification of soman.
Nordgren I; Lundgren G; Puu G; Holmstedt B
Arch Toxicol; 1984 Mar; 55(1):70-5. PubMed ID: 6732508
[TBL] [Abstract][Full Text] [Related]
20. Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity.
Chambers JP; Hartgraves SL; Murphy MR; Wayner MJ; Kumar N; Valdes JJ
Neurosci Biobehav Rev; 1991; 15(1):85-8. PubMed ID: 2052204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
